NDC 0054-0576
Deferiprone
Deferiprone
Deferiprone is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Hikma Pharmaceuticals Usa Inc.. The primary component is Deferiprone.
| Product ID | 0054-0576_1bf38cd2-7229-42e1-aec3-70402c17ae39 |
| NDC | 0054-0576 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Deferiprone |
| Generic Name | Deferiprone |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-06-03 |
| Marketing Category | ANDA / |
| Application Number | ANDA213239 |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Substance Name | DEFERIPRONE |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Iron Chelating Activity [MoA],Iron Chelator [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 0054-0576-25
100 TABLET, COATED in 1 BOTTLE (0054-0576-25)
| Marketing Start Date | 2021-06-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
NDC Crossover Matching brand name "Deferiprone" or generic name "Deferiprone"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0576 | Deferiprone | Deferiprone |
| 0054-0711 | Deferiprone | Deferiprone |
| 51672-4196 | Deferiprone | Deferiprone |
| 10122-100 | FERRIPROX | deferiprone |
| 10122-101 | FERRIPROX | deferiprone |
| 10122-103 | FERRIPROX | DEFERIPRONE |
| 10122-104 | FERRIPROX | deferiprone |
| 52609-0006 | FERRIPROX | deferiprone |
| 52609-0007 | FERRIPROX | deferiprone |
| 52609-4502 | FERRIPROX | deferiprone |
Trademark Results [Deferiprone]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 DEFERIPRONE 97303966 not registered Live/Pending |
Beer, Kenneth 2022-03-09 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.